Characterization of DLBCL with a PMBL gene expression signature
Gerben Duns(Spinal Cord Injury BC), Christian Steidl(University of British Columbia), Pedro Farinha, Katsuyoshi Takata(Spinal Cord Injury BC), Laura K. Hilton(BC Cancer Agency), Jeffrey W. Craig(Rockefeller University), Aixiang Jiang(Simon Fraser University), Kerry J. Savage(Spinal Cord Injury BC), Stacy Hung(Spinal Cord Injury BC), David W. Scott(BC Cancer Agency), Susana Ben‐Neriah(Apple (Israel)), Christopher Rushton(Simon Fraser University), Randy D. Gascoyne(BC Cancer Agency), Sohrab P. Shah(Memorial Sloan Kettering Cancer Center), Clémentine Sarkozy(Spinal Cord Injury BC), Graham W. Slack(BC Cancer Agency), Daisuke Ennishi(BC Cancer Agency), Elizabeth A. Chavez(Spinal Cord Injury BC), Ryan D. Morin(Simon Fraser University), Anja Mottok(Comprehensive Cancer Center Mainfranken), Elena Viganò(University of Urbino), Eric D. Hsi(Mayo Clinic), Bruce W. Woolcock(Spinal Cord Injury BC)
Cited by 35
Related Papers
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k